Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer OyfiledCriticalBayer Oy
Publication of AR098060A1publicationCriticalpatent/AR098060A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Orthopedics, Nursing, And Contraception
(AREA)
Abstract
Método anticonceptivo mejorado que aborda los problemas de las hemorragias iniciales y las hemorragias irregulares asociadas al uso de los sistemas de administración intrauterina. Sistema de administración intrauterina mejorado.Improved contraceptive method that addresses the problems of initial bleeding and irregular bleeding associated with the use of intrauterine administration systems. Improved intrauterine administration system.
ARP140103863A2013-10-182014-10-17
INTRAUTERINE ADMINISTRATION SYSTEM
AR098060A1
(en)
Compounds derived from thieno [2,3-c] pyran with modulating activity of the cystic fibrosis transmembrane conductance regulator (cftr); pharmaceutical composition that includes them; Useful in the treatment of cystic fibrosis.